Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis
Babita Aneja, Nashrah Sharif Khan, Parvez Κhan, et al.
European Journal of Medicinal Chemistry (2018) Vol. 163, pp. 840-852
Closed Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
Zhi Xu, Shijia Zhao, Yi Liu
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111700-111700
Closed Access | Times Cited: 414
Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency
Raphael Enoque Ferraz de Paiva, Eduardo Guimarães Vieira, Daniel Rodrigues da Silva, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 116
Hydrazide-hydrazone/hydrazone as enabling linkers in anti-cancer drug discovery: A comprehensive review
Solai Murugappan, Sowmya Dastari, Kalyani Jungare, et al.
Journal of Molecular Structure (2024) Vol. 1307, pp. 138012-138012
Closed Access | Times Cited: 21
Recent advances in isatin hybrids as potential anticancer agents
Zhen Ding, Minfeng Zhou, Cheng Zeng
Archiv der Pharmazie (2020) Vol. 353, Iss. 3
Closed Access | Times Cited: 99
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
Anas Shamsi, Saleha Anwar, Taj Mohammad, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 95
Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances
Prajwal Dhokne, Akash P. Sakla, Nagula Shankaraiah
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113334-113334
Closed Access | Times Cited: 83
Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses
Nadjet Rezki, Meshal A. Almehmadi, Saleh Ihmaid, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104133-104133
Closed Access | Times Cited: 75
Acylhydrazones and Their Biological Activity: A Review
Laura Ileana Socea, Ștefania‐Felicia Bărbuceanu, Elena Pahonţu, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8719-8719
Open Access | Times Cited: 49
A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs)
Shefali Chowdhary, Shalini Shalini, Amandeep Arora, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 536-536
Open Access | Times Cited: 43
Ionic liquids revolutionizing biomedicine: recent advances and emerging opportunities
Yanhui Hu, Yuyuan Xing, Hua Yue, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 20, pp. 7262-7293
Open Access | Times Cited: 33
A Mini Review on Pharmacological Significance of Isatin-1,2,3-Triazole Hybrids
Aman Kumar, Yajat Rohila, Vijay Kumar, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 833-847
Closed Access | Times Cited: 23
A survey of isatin hybrids and their biological properties
Vanessa Asoh Shu, Donatus Bekindaka Eni, Fidele Ntie‐Kang
Molecular Diversity (2024)
Open Access | Times Cited: 10
Novel isatin–triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies
Alia Mushtaq, Rabbia Asif, Waqar Ahmed Humayun, et al.
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14051-14067
Open Access | Times Cited: 9
A Comprehensive Review of the Diverse Spectrum Activity of 1,2,3‐Triazole‐linked Isatin Hybrids
Yajat Rohila, Sharol Sebastian, Azaj Ansari, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 7
Isatin–azole hybrids and their anticancer activities
Yani Hou, Congshan Shang, Hui Wang, et al.
Archiv der Pharmazie (2019) Vol. 353, Iss. 1
Closed Access | Times Cited: 69
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies
Wagdy M. Eldehna, Sara T. Al‐Rashood, Tarfah Al‐Warhi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 36, Iss. 1, pp. 271-286
Open Access | Times Cited: 65
Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases
Saleha Anwar, Shama Khan, Anas Shamsi, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 10, pp. 1445-1459
Closed Access | Times Cited: 53
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 12, pp. 1059-1073
Closed Access | Times Cited: 51
Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors
Tarfah Al‐Warhi, Ahmed M. El Kerdawy, Nada Aljaeed, et al.
Molecules (2020) Vol. 25, Iss. 9, pp. 2031-2031
Open Access | Times Cited: 51
Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications
Urooj Fatima, Sonam Roy, Shahnawaz Ahmad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113469-113469
Closed Access | Times Cited: 34
The Effect of 1,2,4-Triazole-3-thiol Derivatives Bearing Hydrazone Moiety on Cancer Cell Migration and Growth of Melanoma, Breast, and Pancreatic Cancer Spheroids
Aida Šermukšnytė, Kristina Kantminienė, Ilona Jonuškienė, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1026-1026
Open Access | Times Cited: 31
Synthesis of Functionalized 2′,5‐Oxo‐spiro[furan‐2,3′‐indoline]‐3‐carboxylate Derivatives as Antiproliferative Agents: ADMET Studies, and Molecular Docking against P2Y12 Inhibitors
Mohd Asif, Mohammad Saquib, Abdul Rahman Khan, et al.
ChemistrySelect (2023) Vol. 8, Iss. 11
Closed Access | Times Cited: 15
Synthesis, characterization, PXRD studies, and theoretical calculation of the effect of gamma irradiation and antimicrobial studies on novel Pd(II), Cu(II), and Cu(I) complexes
Safaa S. Hassan, Samar A. Aly, Ahlam I. Al‐Sulami, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 6
Design, synthesis, in vitro, and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents
Iqra Munir, Zahra Batool, Faizullah Khan, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 948-965
Open Access
Therapeutic Insights of Indole Scaffold‐Based Compounds as Protein Kinase Inhibitors
Dina H. Dawood
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
Page 1 - Next Page

Scroll to top